Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.
Saved in:
| Title: | Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research. |
|---|---|
| Authors: | Kataria B; Department of Medical Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India., Mukhopadhyay A; Kolkata Gynecological Oncology Trials and Translational Research Group, Kolkata, India., Oaknin A; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain., O'Donnell DM; Department of Medical Oncology, St James's Hospital, Dublin, Ireland., Tan DSP; Cancer Science Institute, NUS Department of Medicine, Yong Loo Lin School of Medicine, National University Cancer Institute, National University Hospital, Singapore., Cibula D; Department of Gynaecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Bleeker MCG; Department of Pathology, Amsterdam University Medical Center, Amsterdam, Netherlands., Plante M; Quebec University Hospital Center, Quebec City, QC, Canada., Chargari C; Radiation Oncology Department, Pitié Salpêtrière University Hospital, Paris, France; Radiation Oncology Department, Sorbonne University, Paris, France., Brand A; Department of Gynae-Oncology, Westmead Hospital, Sydney, NSW, Australia., Lorusso D; European Institute of Onocology, Ginecologia Oncologica Medica, Milan, Italy., Mayadev J; Radiation Medicine and Applied Science, University of California, San Diego, CA, USA., Leary A; Department of Medical Oncology, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France., Hasegawa K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan., Kohn EC; National Cancer Institute, Rockville, MD, USA., Mendez LC; Department of Oncology, Verspeeten Family Cancer Centre, Western University, London Health Sciences Centre, London, ON, Canada., Maguire PJ; Trinity St James's Cancer Institute, Division of Gynaecological Oncology, St James's Hospital, Dublin, Ireland., Garcia-Duran C; Gynaecologic Cancer Programme, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Hanly K; Cancer Trials Ireland, Dublin, Ireland., Malhotra P; Kolkata Gynecological Oncology Trials and Translational Research Group, Pune, India., Emery L; National Cancer Institute, Bethesda, MD, USA., Happy M; Kyenjojo, Uganda., Nout RA; Department of Radiotherapy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Lecuru F; Department of Gynecological Oncology, Institut Curie, Paris, France; Faculty of Medicine, Paris Cité University, Paris, France; Institut Curie, University Hospital Institute for Women's Cancers, Paris, France., Covens A; Department of Gynecologic Oncology, University of Toronto, Toronto, ON, Canada., Stuart GCE; Department of Obstetrics and Gynecology, University of British Colombia, Vancouver, BC, Canada., Oza AM; Division of Medical Oncology and Hematology, UHN-Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Bookman MA; Department of Medical Oncology, Kaiser Permanente Northern California, San Francisco, CA, USA. Electronic address: michael.a.bookman@kp.org. |
| Corporate Authors: | participants of the 2024 Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research |
| Source: | The Lancet. Oncology [Lancet Oncol] 2026 Aug; Vol. 27 (8), pp. e379-e391. |
| Publication Type: | Consensus Statement; Journal Article; Review |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
